Beyond The Graft: Synthetic Scaffolds For Soft-Tissue Reconstruction
This article was originally published in Start Up
Executive Summary
A field littered with failures sees few companies brave enough to try again. A big market awaits medtech start-ups that find a successful way to end the need for autografts and allografts for soft-tissue repair.
You may also be interested in...
New Technologies Drive Growth In Orthopedic Extremities Market
While the mature hips, knees, and spine segments of the orthopedics industry are growing by low single-digit rates, some sectors of the extremity industry are growing by 13% to 14%. We profile three companies in different sectors of extremities: Conventus Orthopaedics, in the hand and wrist market; Nextremity Solutions, working on devices for the forefoot; and Cartiva Medical, with a cartilage platform and an initial focus on the great toe.
ArthroCare Bid Signals Ortho Consolidation
If completed, Smith & Nephew’s acquisition of ArthroCare would help it diversify into the ENT market, but the deal may not get done as analysts speculate that competitors Stryker and J&J could step in with counteroffers. But the interest surrounding Austin, TX-based ArthroCare emphasizes the pressures being put on large joint makers to find new ways of making money in orthopedics.
Innovation Is Alive And Well In Sports Medicine
The sports medicine market comprises a number of product segments, many of which span several different orthopedics specialties.This space is expected to experience strong growth going forward as companies develop innovative ways, including some lower-cost approaches, to treat the joint and soft-tissue injuries commonly suffered by athletes and other sports enthusiasts.